Pharmacokinetics and biodistribution of nanoparticles.

By Shyh-Dar Li, Leaf Huang. Molecular Pharmaceutics, 2008

1,525 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The role of lipid components in lipid nanoparticles for vaccines and gene therapy (2022, positive): “LNP size must be controlled during preparation as it plays a decisive role in nanoparticle pharmacokinetics and biodistribution [62] and LNP biodistribution, delivery efficiency, and transfection potency [63].”
Metal-Organic Frameworks as Potential Drug Carriers (2010, neutral): “NMOFs can improve the pharmacokinetic properties of the encapsulated drugs [1,5,7].”
Bio-Nanocomposites for Food Packaging Applications (2013, background): “Nano-sized particles frequently exhibit different properties from those found at the macro-scale, because the very small sizes of the former, in principle, would allow them to move through the body more freely than larger particles, while their high surface area increases their reactivity and allows”